Clinical studies have shown a direct and significant relationship between urinary protein excretion and serum TNF-α in patients with normal renal function and diabetes, and the fact that urinary TNF-α excretion increases significantly with DN progression strongly supports the prospect of using this cytokine as a biomarker for predicting DN [26,27]. This evidence concerns the gene TNF and liver dysplastic nodule.